RxDoctor Payments Data

Tonda Wooten

Foot & Ankle Surgery · Macon, GANPI 1841641974

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Stryker at 24.3% of the total. Reporting peaked in 2022 at $2,648 and has fallen 83.4% since, to $441 in 2025.

$7,033in general payments, 2019–2025

Across 73 payments — averaging $96.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Arthrex$2K
  • Medline Industries LP$1K
  • Orthofix Medical, Inc.$788
  • United Orthopedics LLC$383
  • Medartis Inc.$333
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$3,23846%
  • Food & beverage$2,56737%
  • Education$1,20017%
  • Gifts$280%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,033 in reported general payments places this provider in the 75th percentile of 239 foot & ankle surgery providers in Georgia.

See all foot & ankle surgery providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.15$7,720
Ciclopirox42$1,166
Lidocaine-PrilocaineLidocaine/Prilocaine11$229
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$209
Methylprednisolone13$123
Levofloxacin15$122
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$85$7,72015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 239 foot & ankle surgery providers in Georgia.

Other foot & ankle surgery in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →